Mark Hillman's Portfolio Shows Mixed Quarterly Activity
Mark Hillman's Hillman Value Fund portfolio, valued at approximately $144 million as of March 31, 2026, displayed significant changes in holdings, with notable increases in CARMAX INC (KMX) and DUPONT DE NEMOURS INC (DD), alongside substantial decreases in stocks like WARNER BROS DISCOVERY INC (WBD).
As of March 31, 2026, Mark A. Hillman's Hillman Value Fund portfolio held a total value of approximately $144,004,744. The portfolio's top holdings, representing significant allocations, showed varied changes during the quarter.
Among the notable movements, CARMAX INC (KMX) saw a substantial increase in shares, rising by 19.34%. Investors can explore KMX's profile at https://www.insiderset.com/investors/stocks/KMX.
DUPONT DE NEMOURS INC (DD) also experienced a significant increase, with a 65.65% rise in shares. For more information on DD, visit https://www.insiderset.com/investors/stocks/DD.
Conversely, WARNER BROS DISCOVERY INC (WBD) faced a substantial decrease, with shares falling by 40.64%. Further details on WBD are available at https://www.insiderset.com/investors/stocks/WBD.
Other significant decreases were observed in BIOGEN INC (BIIB) (-22.98%), GSK PLC (GSK) (-31.28%), PFIZER INC (PFE) (-13.21%), and CVS HEALTH CORP (CVS) (-18.09%). Investors can find more details on these companies by visiting their respective profiles on Mark Hillman's investor page.
Some positions remained relatively stable or showed modest changes, such as INTERNATIONAL FLAVORS&FRAGRA (IFF) (-8.19%), ZIMMER BIOMET HOLDINGS INC (ZBH) (+5.46%), and BROWN FORMAN CORP (BF-B) (-6.28%).
For a comprehensive view of Mark Hillman's investment activities, please visit his profile at https://www.insiderset.com/investor/mark-a-hillman-hillman-capital-management.